RaySearch Laboratories AB has launched the latest release of its widely adopted treatment planning system. RayStation 10B adds support for brachytherapy planning and a new GPU Monte Carlo algorithm, which typically cuts final dose computation times to less than five seconds.

December 29, 2020 — RaySearch Laboratories AB has launched the latest release of its widely adopted treatment planning system. RayStation 10B adds support for brachytherapy planning and a new GPU Monte Carlo algorithm, which typically cuts final dose computation times to less than five seconds.

In line with the company’s aim of integrating with as many treatment delivery systems as possible, the new release includes support for high-dose-rate (HDR) brachytherapy planning. RayStation 10B features automatic channel reconstruction in combination with powerful dwell-time optimization, enabling faster and more consistent creation of high-quality brachytherapy plans. The efficiency and possibilities of brachytherapy planning are further enhanced by tools for working with multiple image sets, image deformation and dose summation. 

HDR brachytherapy is a radiation therapy technique in which a small radioactive source is placed at different positions inside the patient to obtain an advantageous dose distribution. High doses can be delivered to tumors while sparing organs at risk. The technique is used, for example, to treat gynecological, prostate, breast, head-and-neck and skin cancers.

Another notable addition in RayStation 10B is the multi-GPU Monte Carlo dose engine for proton planning. With typical final dose computation times of less than five seconds, the GPU Monte Carlo algorithm is expected to revolutionize planning workflows at proton clinics. The physics algorithms of the GPU proton Monte Carlo dose engine are identical to those in the now well-established RayStation CPU proton Monte Carlo dose engine, and dosimetric results are equally strong.

Machine-learning capabilities were introduced in RayStation 8B and are being continuously improved with each successive release. In RayStation 10B, machine learning applications further increase efficiency and improve consistency for photon and robust proton planning, and deep-learning organ segmentation. 

The robust optimization framework has been extended to take intra- and inter-fractional motion into account, with consideration for motion during the delivery of single fractions and changes over the entire treatment course. This framework supports improved plan quality, for example in cases with organ motion. 10B also introduces machine parameter improvements to utilize the full potential of the most common linacs. As a result, it is now possible to create treatment plans with more conformal dose distribution and lower dose to organs at risk.

Other enhancements include closer integration with the oncology information system RayCare. When running RayStation in a RayCare environment, the planning task list is now accessible in RayStation for improved workflow management.

Johan Löf, CEO of RaySearch, said: “Each release of RayStation takes clinical workflows to the next level. Brachytherapy is a highly accurate technique, and the capabilities of our advanced software will bring a new dimension to the treatment of several cancer types.”

For more information: www.raysearchlabs.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
News | Radiology Business

July 31, 2024 — The American Registry of Radiologic Technologists (ARRT) announced the three Registered Technologists (R ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | Radiation Therapy

July 22, 2024 — RefleXion Medical, an external-beam theranostic oncology company, today announced that researchers from ...

Time July 22, 2024
arrow
News | ASTRO

July 18, 2024 — The members of the American Society for Radiation Oncology (ASTRO) recently elected five new officers to ...

Time July 18, 2024
arrow
News | PET-CT

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
News | Digital Pathology

July 12, 2024 — AGFA HealthCare, a global leader in healthcare imaging management solutions, announced that Enterprise ...

Time July 12, 2024
arrow
News | Digital Pathology

July 12, 2024 — Diagnosing cancer and providing the personalized therapy it often requires, is a collaborative effort ...

Time July 12, 2024
arrow
Subscribe Now